Copyright
©The Author(s) 2022.
World J Clin Cases. May 16, 2022; 10(14): 4348-4356
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4348
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4348
Figure 2 Possible mechanisms of action of adipose-derived mesenchymal stem cells in liver disease and inflammation.
AD-MSC: Adipose-derived mesenchymal stem cells, ECM: Extracellular matrix, MMP: Matrix metalloproteinase, TIMP: Tissue inhibitor of matrix metalloproteinase, TGF-β1: Transforming growth factor-β1.
- Citation: Satilmis B, Cicek GS, Cicek E, Akbulut S, Sahin TT, Yilmaz S. Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis. World J Clin Cases 2022; 10(14): 4348-4356
- URL: https://www.wjgnet.com/2307-8960/full/v10/i14/4348.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i14.4348